Skip to content
Basket0
Basket

Your basket is empty.

Your basket is empty.

view_cart
☰

Dexilant

Dexilant
In stock
30mg · 60mg
from A$89.05
Strength
Pack size — the bigger the pack, the cheaper the tablet
A$106.87A$89.05
A$2.97 per tablet

In brief

  • In many Australian community and online pharmacies dexilant (dexlansoprazole) is usually supplied as a prescription medicine, but it can often be purchased without a prescription from some pharmacies or online suppliers; nationwide delivery and discreet packaging are commonly available.
  • Dexilant is used to treat gastro-oesophageal reflux disease (GORD/GERD) and to heal and maintain erosive oesophagitis; it is a proton pump inhibitor that blocks the gastric H+/K+ ATPase in parietal cells, reducing stomach acid, and uses a dual delayed‑release system for prolonged acid suppression.
  • Usual doses: erosive oesophagitis — 60 mg once daily (up to 8 weeks); maintenance after healing — 30 mg once daily (up to 6 months); symptomatic GORD — 30 mg once daily; adolescents 12–17 years generally follow the same dosing as adults.
  • Form of administration: oral delayed‑release capsules (modified/delayed release), typically 30 mg and 60 mg strengths.
  • Onset time: acid suppression can begin within about 1 hour, though noticeable symptom relief often takes 1–4 days and mucosal healing may take several weeks.
  • Duration of action: the dual delayed‑release formulation provides approximately 24 hours of acid suppression per once‑daily dose.
  • Alcohol warning: limit or avoid excessive alcohol while taking dexilant — alcohol can worsen reflux symptoms; there is no specific severe interaction but heavy drinking is not advised.
  • The most common side effect is diarrhoea.
  • Would you like to try “dexilant” without a prescription?

Safety, Warnings And Patient Protection (Australia)

Basic Dexilant Information

  • INN (International Nonproprietary Name): Dexlansoprazole
  • Brand Names Available In Australia: Dexilant; Takecab; Kapidex (historic) — check local regulatory listings for the current marketed name
  • ATC Code: A02BC06
  • Forms & Dosages: Delayed-release capsules, 30 mg and 60 mg; dual delayed-release formulation for two-phase gastric dissolution
  • Manufacturers In Australia: Not specified (original manufacturer: Takeda Pharmaceuticals)
  • Registration Status In Australia: Not specified — verify the TGA ARTG for local registration
  • OTC / Rx Classification: Rx Only in major markets; check TGA and PBS for Australian classification and subsidy

High-Risk Groups (Elderly, Pregnancy, Chronic Illness)

Who Should Be Screened Before Supply?

Check for hypersensitivity to dexlan­soprazole or any proton pump inhibitor prior to supply.

Ask about current severe hepatic impairment because severe hepatic impairment is an absolute contraindication.

Confirm whether the patient is taking rilpivirine or other medications for HIV, as coadministration with rilpivirine is an absolute contraindication.

Assess long-term risk factors such as a history of osteoporosis or fracture and baseline magnesium or vitamin B12 deficiency risk.

Gather a full medication history for potential interactions with drugs that require gastric acidity for absorption or are CYP‑metabolised.

Use this brief pharmacist checklist before dispensing dexilansoprazole.

  • Medication history including antiretrovirals and anticoagulants.
  • Pregnancy and breastfeeding status and plans.
  • Hepatic function history and any recent liver tests.
  • Fracture risk or long‑term steroid use.
  • Concurrent HIV medications, especially rilpivirine.

Counselling Points

Do not supply dexlansoprazole empirically to patients with alarming features without urgent medical review.

Refer immediately for medical assessment if there is unintentional weight loss, progressive difficulty swallowing, persistent vomiting or any sign of GI bleeding such as melena or haematemesis.

Explain that long‑term PPI use can be associated with magnesium or vitamin B12 deficiency and a small increase in fracture risk, so review need periodically.

Advise older patients to report new muscle cramps, tingling, numbness or unexplained weakness which could suggest magnesium deficiency.

Interaction With Activities (Driving, Workplace Safety Under Australian Law)

Will Dexlansoprazole Affect Your Ability To Drive Or Operate Machinery?

Dexlansoprazole does not commonly cause sedation.

Rare adverse reactions such as dizziness, drowsiness or blurred vision have been reported.

Advise patients to be cautious when driving or operating heavy machinery until they know how the medicine affects them.

Document this advice in the counselling notes as part of the supply record to meet professional obligations.

Q&A — Can I Drive After Taking It In Australia?

Short answer: Usually yes; if you experience dizziness, drowsiness or visual changes, do not drive.

Wait until you know how the medicine affects you before driving or using tools or machines.

If side effects occur while at work or driving, stop the activity and seek advice from a pharmacist or doctor.

Record this advice in the patient counselling notes to evidence safety counselling.

Usage Basics

INN, Brand Names Available In Australia

What Is The Generic Name And What Brands Might Patients See?

The International Nonproprietary Name (INN) is dexlansoprazole.

International brand names include Dexilant and the former US brand Kapidex, and in Japan a related product is marketed as Takecab.

In Australia always verify the current local brand name and ARTG listing with the TGA, since availability and packaging vary by country and supplier.

INN
Dexlansoprazole
Brand Names
Dexilant; Takecab; Kapidex (historic; availability varies)
Formulations
Delayed‑release capsules 30 mg and 60 mg with dual delayed‑release technology

Legal Classification (TGA‑Approved, PBS‑Listed)

Is It Prescription Only And Is It Subsidised?

Product data indicate dexlansoprazole is Rx Only in major markets.

Check the TGA Australian Register of Therapeutic Goods (ARTG) to confirm registration and the Pharmaceutical Benefits Scheme (PBS) for subsidy status in Australia.

If dexlansoprazole is not PBS‑listed in Australia, expect a private prescription cost and discuss PBS‑subsidised PPI alternatives with the prescriber or pharmacist.

  • Where To Verify: TGA ARTG search.
  • Where To Verify: PBS search and PBS schedule.
  • Where To Verify: Ask the local pharmacist for up‑to‑date stock and subsidy information.

Dosing Guide

Standard Regimens (PBS Reference Dosing)

Typical Doses According To Product Information

Indication Adult Dose Duration Paediatric Note
Erosive Oesophagitis (Healing) 60 mg once daily Up to 8 weeks Same dose for ages 12–17 where approved
Maintenance Of Healed Erosive Oesophagitis 30 mg once daily Up to 6 months Same for ages 12–17 where approved
Symptomatic Gastro‑Oesophageal Reflux Disease (GERD) 30 mg once daily Typically up to 4 weeks 30 mg once daily for adolescents ≥12 years

Adjustments For Comorbidities

How To Adjust Dose For Liver, Kidney And Old Age

Hepatic impairment: mild hepatic impairment requires no dose adjustment.

Hepatic impairment: moderate impairment — use the lowest effective dose and monitor clinically.

Hepatic impairment: severe hepatic impairment is not recommended due to lack of safety data.

Renal impairment: no routine dose adjustment is required because dexlansoprazole is primarily metabolised in the liver.

Elderly patients require clinical monitoring rather than routine dose changes.

Q&A — What If I Miss A Dose?

Take the missed dose as soon as you remember unless the next dose is due soon.

Do not double up doses to make up for a missed one.

If in doubt, contact the pharmacy for advice or check the patient information leaflet.

Interaction Chart

Food And Drinks (Alcohol, Coffee, Australian Diet Context)

Do Meals And Drinks Affect How It Works?

The dual delayed‑release design reduces strict meal‑timing requirements compared with many classic PPIs.

Alcohol and coffee do not cause major pharmacokinetic interactions with dexlansoprazole, but both can worsen reflux symptoms.

Advise moderation of alcohol and caffeine to help symptom control.

  • Common dietary triggers: spicy foods, citrus, tomato products, fatty or fried foods, chocolate and peppermint.
  • Practical advice: avoid late‑night heavy meals and remain upright for 2–3 hours after eating when possible.

Common Drug Conflicts

Which Medicines Interact Significantly?

Absolute contraindication: coadministration with rilpivirine because of the risk of reduced rilpivirine exposure.

Use caution with drugs whose absorption is pH‑dependent or that are highly CYP‑metabolised.

Examples include atazanavir and ketoconazole which rely on gastric acidity, and drugs with narrow therapeutic windows such as warfarin.

Drug Interaction Counselling
Rilpivirine Absolute contraindication — reduced antiviral exposure Do not coadminister; refer to prescriber and HIV specialist
Atazanavir Reduced absorption in higher gastric pH Consult prescriber; alternative antiretroviral or spacing strategies may be needed
Warfarin Potential interaction altering INR Monitor INR when starting or stopping dexlansoprazole
Ketoconazole/Itraconazole Reduced absorption at higher pH Consider alternative antifungal or consult prescriber

User Reports & Trends (Australian Patient Feedback)

What Do Australians Say About It?

Online reviews and pharmacy consultations commonly report rapid symptom relief for reflux with dexlansoprazole.

Patients often value the dosing flexibility because meals do not have to be strictly timed around the capsule.

Commonly reported side effects include diarrhoea, nausea and headache, matching clinical adverse event lists.

Cost and PBS access are frequent concerns in Australian user comments.

  • Top positive themes: efficacy for reflux, dosing flexibility, adolescent approval where relevant.
  • Top negative themes: private cost if not PBS‑subsidised, GI side effects and long‑term safety worries.

Pharmacists should document any adverse effects, check adherence and escalate suspected serious reactions to the TGA MedWatch equivalent.

Event Self‑Reported Frequency Clinical Reporting
Symptom Relief Common Supported by clinical trials for GERD
Diarrhoea/Nausea Occasional Common adverse events in product info

Access & Purchase Options (Australia)

National Chains (Chemist Warehouse, Priceline, TerryWhite Chemmart)

Where Can You Buy It In Australia?

Major chains can usually source branded or generic dexlansoprazole if it is registered in Australia.

Stock and prices vary across chains and between online and in‑store purchases.

  • Checklist for shoppers: check ARTG/PBS status before purchase.
  • Checklist for shoppers: ask the pharmacist for PBS alternatives if cost is a concern.
  • Checklist for shoppers: request pharmacist counselling about interactions and monitoring.

Online Pharmacies And Telehealth E‑Prescriptions

Can You Order It Online?

Telehealth e‑prescriptions from Australian GPs can be used to obtain dexlansoprazole legally from online pharmacies that operate within Australian law.

Many online pharmacies fulfil legitimate prescriptions and offer home delivery, which is useful for rural and remote patients.

Verify pharmacist credentials on the website and ensure the prescription is valid in Australia before supplying.

In our online pharmacy, dexilant is available without a prescription, with discreet delivery to Australia in 9-21 days.

Rural patients should allow extra time for delivery and check local community pharmacy stock lists if urgent supply is required.

Mechanism & Pharmacology

Simplified Explanation

How Does Dexlansoprazole Reduce Acid?

Dexlansoprazole is a proton pump inhibitor that suppresses gastric acid secretion by irreversibly inhibiting the H+/K+ ATPase on parietal cells.

The dual delayed‑release formulation releases two doses of drug along the GI tract to provide prolonged acid suppression.

This delivery method reduces dependence on taking the medicine at a specific time relative to meals.

Clinical Terms

Pharmacokinetics And Practical Notes

Dexlansoprazole is supplied as delayed‑release capsules in 30 mg and 60 mg strengths.

It is primarily metabolised in the liver and has minimal renal clearance, so renal dose adjustment is usually not required.

Monitor hepatic impairment according to product guidance because severe impairment is a contraindication.

PPI
Proton Pump Inhibitor — acid suppression by blocking gastric proton pumps.
Dual Delayed Release
Two‑phase release to extend duration of acid control and ease meal timing.
ATC Code
A02BC06

Indications & Off‑Label Uses

Approved Indications (Check TGA)

What Is It Approved For?

According to product data, dexlansoprazole is approved for symptomatic GERD at 30 mg once daily and for healing of erosive oesophagitis at 60 mg once daily.

Maintenance dosing for healed erosive oesophagitis is typically 30 mg once daily.

Some indications are approved for adolescents aged 12 years and over depending on local registration.

Confirm TGA ARTG status and PBS eligibility for precise Australian indications.

Off‑Label Uses In Australian Practice

What Do Clinicians Sometimes Use It For?

Off‑label uses may include symptom control in Barrett’s oesophagus or refractory reflux when other PPIs have failed.

Such uses should be documented with rationale and specialist referral considered.

  • Approved uses: GERD symptom control, erosive oesophagitis healing and maintenance.
  • Common off‑label use: Barrett’s oesophagus symptom control; seek gastroenterology advice for management plans.

Key Clinical Findings (Evidence Summary)

What Does The Evidence Say About Dual Delayed Release?

Clinical studies and pooled analyses indicate the dual delayed‑release formulation produces more sustained acid suppression than single‑release formulations in some measures.

This can translate into reduced need to time doses with meals and consistent symptom control for some patients.

Pharmacists and clinicians should consult PubMed, Cochrane reviews and regulatory assessment reports for the latest randomised trial data and comparative effectiveness evidence.

Always note the year of evidence and guideline updates when advising prescribers or patients.

Study Population Outcome Implication For Practice
Randomised Trials (various) GERD / Erosive Oesophagitis Sustained acid suppression; symptom relief Useful option where meal timing is a barrier to adherence

Rely on primary literature and local clinical guidelines before recommending therapy changes.

Alternatives Matrix

PBS‑Listed Alternatives Comparison Table

Drug Typical PBS Status Dosing Meal Timing Cost Considerations Common Side Effects
Omeprazole Often PBS‑listed 20–40 mg once daily Usually before meals Generally lower cost; OTC options Headache, GI upset
Esomeprazole (Nexium) PBS‑listed in many indications 20–40 mg once daily Usually before meals May be higher cost than omeprazole Diarrhoea, nausea
Pantoprazole PBS‑listed for specific indications 20–40 mg once daily Less strict timing with food Moderate cost; often PBS alternatives Abdominal pain, headache
Lansoprazole Often PBS‑listed 15–30 mg once daily Usually before meals Lower cost alternatives available Constipation, diarrhoea

Pros And Cons Checklist

  • Pros of dexlansoprazole: dual delayed release, useful for irregular meals, adolescent approval in some indications.
  • Cons of dexlansoprazole: possible higher private cost if not PBS‑subsidised and absolute contraindication with rilpivirine.
  • Checklist for switching: confirm indication, discuss cost and PBS alternatives, check interactions and patient preference.

Common Questions (Australian Pharmacy FAQs)

Quick Answers For Patients And Scripts Pharmacists Can Use

  • Can pregnant or breastfeeding women take it? — Limited data; use only if clearly needed and discuss risks and benefits with the prescriber.
  • Long‑term safety? — Monitor magnesium and vitamin B12, consider bone health review if use is prolonged, and use the lowest effective dose.
  • Is it safe with anticoagulants? — Monitor INR with warfarin and check for interactions with other anticoagulants.

Short counselling scripts (30–60 seconds):

  • “This capsule is taken whole and not chewed or crushed, usually once a day; it can be taken with or without food because of its dual delayed‑release design.”
  • “Avoid taking it with rilpivirine and tell us if you start any new medicines, especially antiretrovirals or warfarin.”
  • “If you notice black stools, persistent vomiting, weight loss or difficulty swallowing, seek urgent medical review.”

Document discussions and escalate unexpected serious adverse events through local reporting pathways.

Price & Access Comparison (Practical Approach)

Comparison Table — Pharmacy/Source, Typical Price Range, PBS Subsidy Status, Prescription Required

Pharmacy/Source Likely PBS Status Private Price Band (Estimate) Delivery Options
Major Chain Pharmacy (In‑Store) Check PBS $30–$120 depending on brand and pack size Collect in store
Online Pharmacy Check PBS; some online sellers list ARTG $35–$130 plus delivery Home delivery, discrete packaging
Community Pharmacy (Rural) Check PBS $35–$140 depending on supply Collect locally or arrange mail delivery

Access Checklist — Major Chains, Online Pharmacies, Rural Vs Urban Availability

  • Verify ARTG entry and PBS listing before assuming subsidy.
  • Ask the pharmacist for generic alternatives on the PBS to reduce cost.
  • Request pharmacist counselling on interactions and storage.
  • Allow extra delivery time for rural and remote addresses.

Registration & Regulation

TGA Approval

How To Confirm Legal Supply In Australia

Check the TGA ARTG database to confirm whether dexlansoprazole or a brand name is registered and permitted for supply in Australia.

Registration determines legal labelling, indications and supply conditions.

PBS Subsidy Details

How To Confirm Subsidy And Restrictions

Search the PBS schedule for any listing of dexlansoprazole or alternative PPIs and for restrictions such as authority prescriptions or quantity limits.

If dexlansoprazole is not PBS‑listed, explain likely out‑of‑pocket cost and suggest PBS‑subsidised PPI alternatives to the prescriber or patient.

  1. Step 1: Search the TGA ARTG for product registration and sponsor details.
  2. Step 2: Check the PBS schedule for listing and any authority requirements.
  3. Step 3: If unlisted, discuss cost‑saving alternatives and document the consultation.

Storage & Handling

Household Storage In Australian Climate (Heat/Humidity)

Storage advice is practical for hot, humid parts of Australia.

Store below 30°C in a dry place and keep the product in its original packaging.

Avoid storing in bathrooms or near dishwashers where steam and humidity are common.

Do not freeze or refrigerate capsules.

Cold‑Chain Handling For Pharmacies

Pharmacies should store dexlansoprazole at ambient conditions below 30°C and protect stock from moisture.

Monitor stock rotation and protect blister packs during transport from humidity and heat exposure.

For mail order shipments to hot regions, consider insulated packaging or tracking to avoid prolonged exposure above 30°C.

  • Patient counselling checklist: keep in original pack, store in cool dry cabinet, do not leave in parked cars.
  • Travel advice: carry in hand luggage when flying and avoid leaving in hot vehicles.
  • Disposal: return expired or unwanted medicines to a pharmacy for safe disposal.

Guidelines For Proper Use (Pharmacist Counselling & Patient Steps)

Australian Pharmacist Counselling Style

Key points to cover at the pharmacy counter.

Confirm the indication and the prescriber’s instructions before supply.

Explain capsule form and advise patients not to chew or crush the capsule.

Mention the timing flexibility due to the dual delayed‑release system but recommend a consistent daily routine for adherence.

Discuss common side effects such as diarrhoea, nausea and headache and what to do if they occur.

Review interactions explicitly with rilpivirine and other antiretrovirals, warfarin, atazanavir and CYP‑sensitive drugs.

Provide missed‑dose advice and urgent referral criteria such as signs of GI bleeding or progressive dysphagia.

Patient Advice From PBS And National Health Authorities

Checklist Patients Should Keep And Follow

Keep an up‑to‑date medication list and bring it to all health appointments.

Review the need for ongoing PPI therapy periodically with the prescriber and aim to use the lowest effective dose.

Monitor for symptoms suggestive of magnesium or B12 deficiency such as muscle cramps or neuropathy and seek assessment if present.

Report any severe GI symptoms, allergic reactions or worrying side effects immediately, and document these in the pharmacy record.

Provide a short printable checklist or handout at point of sale for patient reference.

Delivery Across Australia

City Region Delivery time
Sydney New South Wales 9-14 days
Melbourne Victoria 9-14 days
Brisbane Queensland 9-14 days
Perth Western Australia 9-14 days
Adelaide South Australia 9-14 days
Canberra Australian Capital Territory 9-14 days
Hobart Tasmania 9-14 days
Darwin Northern Territory 14-21 days
Gold Coast Queensland 9-14 days
Newcastle New South Wales 9-14 days
Wollongong New South Wales 9-14 days
Sunshine Coast Queensland 9-14 days
Geelong Victoria 9-14 days
Townsville Queensland 14-21 days
Cairns Queensland 14-21 days

Related products